In a report issued on May 13, Jason McCarthy from Maxim Group maintained a Buy rating on Capricor Therapeutics (CAPR
Tag: Jason McCarthy
Coherus Biosciences (CHRS) Receives a Buy from Maxim Group
Maxim Group analyst Jason McCarthy assigned a Buy rating to Coherus Biosciences (CHRS – Research Report) yesterday and set a
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioLife Solutions
Cytosorbents (CTSO) Receives a Buy from Maxim Group
Maxim Group analyst Jason McCarthy assigned a Buy rating to Cytosorbents (CTSO – Research Report) yesterday and set a price
Maxim Group Believes Co-Diagnostics (NASDAQ: CODX) Still Has Room to Grow
Maxim Group analyst Jason McCarthy assigned a Buy rating to Co-Diagnostics (CODX – Research Report) yesterday and set a price
Vertex Pharmaceuticals (VRTX) Receives a Hold from Maxim Group
In a report released yesterday, Jason McCarthy from Maxim Group maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research
Maxim Group Remains a Buy on Adial Pharmaceuticals (ADIL)
Maxim Group analyst Jason McCarthy reiterated a Buy rating on Adial Pharmaceuticals (ADIL – Research Report) yesterday and set a